Clinical and diagnostic characteristics of peripheral vasculopathy biomarkers in systemic scleroderma
Journal Title: Серце і судини - Year 2019, Vol 0, Issue 2
Abstract
Vascular lesion is a hallmark of systemic scleroderma (SS). Vasculopathy occurs in every patient with SS. It can be the earliest clinical manifestation or cause the main life‑threatening complications of the disease, and thus determine morbidity and mortality. In SS, progressive vascular damage is characterized by constant activation/damage and apoptosis of endothelial cells, intimal thickening and vasoconstriction, leading to the lumen obliteration. Vascular remodeling leads to a violation of their tone and a decrease in capillary blood flow, followed by tissue ischemia and chronic hypoxia. These phenomena are often accompanied by altered levels of vascular factors. Among the most significant biomarkers of vasculopathy in SS with the greatest evidence base we define anti‑AT1R and anti‑ETAR, soluble intercellular adhesion molecules (sICAM‑1), soluble molecules of adhesion of thrombocyte endothelial cells, placental growth factor (PlGF), pro‑angiogenic angiopoietin‑like protein‑3 (ANGPTL‑3), apelin, chemokines (CXCL5), galectin‑3, E‑selectin, tissue kallikrein, interleukins (IL)‑13 and ‑33, vascular endothelial growth factor (VEGF165b), matrix metalloproteinases‑12, endothelin‑1, nodal adhesion molecules which are associated with the development of either digital ulcers or changes on videocapillaroscopy typical for SS. This shows their active role in the pathogenesis of SS, especially during the disease manifestation. Data is presented on the most significant vascular biomarkers and the main connections between vascular biomarkers and capillaroscopic parameters and/or the presence of digital ulcers in SS. Vascular biomarkers can become prognostic factors of vascular damage at SS, which allows early treatment of vascular complications.
Authors and Affiliations
Ye. D. Yehudina, I. Yu. Golovach
Keywords
Related Articles
- EP ID EP608229
- DOI 10.30978/HV2019-2-83
- Views 125
- Downloads 0
Prognostic value of body weight loss and tissue components in patients with chronic heart failure and reduced left ventricular ejection fraction
The aim — to determine the prognostic value of weight loss (WL) and body tissue components in patients with chronic heart failure (CHF) and reduced left ventricular (LV) ejection fraction (EF). Materials and methods. We...
Surgical treatment of hypertrophic cardiomyopathy: what’s new?
The aim — to investigate the effectiveness of surgical septal myectomy in patients with obstructive form of hypertrophic cardiomyopathy (HCM) and to determine its effect on survival and quality of life. Materials and me...
Endometrioma of the rectus abdominis
Endometriosis is determined if the endometrial tissue is located outside the uterine cavity. Endometrial tissue can be localized in the peritoneum, vagina, scar tissue, cervix, fallopian tubes, rectum, urinary tract, Dou...
Molecular genetic aspects of early diagnosis and personalized treatment of obliterating atherosclerosis of lower limb arteries
Obliterating atherosclerosis of lower limb arteries (OALLA) is a multifactorial disease, which results from the complex influence of genetic, epigenetic and environmental factors. Nowadays the role of about 50 single‑nuc...
Videocapillaroscopy of nail bed in systemic scleroderma: prognostic and diagnostic value
Videocapillaroscopy (VCS) is a unique method of morphological assessment of capillaries of the nail bed which is characterized by the ease and speed of execution, plays a crucial role in the early diagnosis of systemic s...